Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

SNSS $0.65 0.1439 +28.44%
CYTK $11.12 1.1700 +11.76%
SPHS $5.86 0.4600 +8.52%
BDSI $2.55 0.2000 +8.51%
NKTR $17.29 1.1900 +7.39%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

PVCT $0.29 -0.0200 -6.45%
TGTX $5.91 -0.4000 -6.34%
VSTM $1.40 -0.0800 -5.41%
GALE $0.44 -0.0254 -5.40%
NLNK $10.58 -0.5300 -4.77%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | Next > | Last >>

New Study Compares the Adherence of Oral Noncancer Medications Before and After Treatment

(ASCO in Action) July 12, 2016 - A new study featured in the Journal of Oncology Practice compares the adherence of oral noncancer medications before and after treatment in patients with early-stage breast cancer (ESBC) and the possible factors associated with nonadherence.
read article 



Patient Navigation—Process Mapping by Disease Site

(ACCCBuzz) July 13, 2016 - For this patient navigation blog post, let’s talk about a recent hot topic on ACCCExchange, the online discussion forum for ACCC members: At what point in the care continuum do you initiate navigation and support services?
read article 



Society of Surgical Oncology Encourages Providers and Patients to Question Certain Tests and Treatments as part of Choosing Wisely®

(ACCC) July 12, 2016 - On July 12, 2016, the Society of Surgical Oncology (SSO) released a list of specific tests or procedures that are commonly ordered but not always necessary in surgical oncology as part of Choosing Wisely.
read article 



Winning Combination: How Technology And Skills Are Taking Up The Fight Against Cancer

(Forbes) July 13, 2016 - We live in the age of technological change. Advances in medical technology give hope each year to millions of people affected by cancer. On a recent trip to Palo Alto California, I went behind the scenes to look at one of the industries most innovative, Varian Medical Systems.
read article 



A Tumor Board for the World

(Medscape Medical News) July 12, 2016 - A twice-monthly tumor board is available online to oncologists around the world from a United States–based charity that seeks to "customize" cancer care so that is "locally appropriate," according to its founder, Paul Goss, MD, PhD, of the Massachusetts General Hospital Cancer Center in Boston.
read article (free registration required) 



Back to the Future in the Quest for Affordable Cancer Care

(Medscape Medical News) July 13, 2016 - Oncologists will need to drive the development of personalized medicine and consider the repurposing of noncancer drugs, alongside the use of biosimilars, if cancer care is to remain affordable, experts said here at the 18th World Congress on Gastrointestinal Cancer.
read article (free registration required) 



Loxo Oncology Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for LOXO-101

(Yahoo! Finance) July 13, 2016 - Loxo Oncology, Inc. today announced that the FDA has granted Breakthrough Therapy Designation to LOXO-101, a selective inhibitor of tropomyosin receptor kinase (TRK), “for the treatment of unresectable or metastatic solid tumors with NTRK-fusion proteins in adult and pediatric patients who require systemic therapy and who have either progressed following prior treatment or who have no acceptable alternative treatments.”
read article 



Cancer Drug Shows Early Promise for Parkinson's Disease

(U.S. News & World Report/HealthDay News) July 12, 2016 - A drug used to treat leukemia has shown initial signs of promise for advanced cases of Parkinson's disease, researchers are reporting.
read article 



Hops Could Help Reduce Breast Cancer Risk

(ACS News Service Weekly) July 13, 2016 - Scientists are now investigating whether an extract from the plant, whose flower cones are used in beer making, could also help fend off breast cancer.
read article 



Fasting-like Diet Turns The Immune System Against Cancer

(USC News) July 12, 2016 - A low-calorie fasting-like diet, plus chemotherapy, enables the immune system to recognize and kill skin and breast cancer cells, according to a new USC-led study on mice.
read article 



Mayo Clinic Researchers Identify Potential Immunotherapy Drug Combination for Targeting Advanced and Metastatic Cancers

(Mayo Clinic) July 12, 2016 - A drug combination designed to enhance the immune system's ability to zero in and attack cancer cells has shown a pronounced therapeutic effect against advanced and metastatic cancers in mice, according to a Mayo Clinic study, published in the July 12 edition of the online journal Oncotarget.
read press release 



Cutting Nerves During Breast Cancer Surgery Is Associated With Chronic Pain

(McMaster University [Ontario, Canada]) July 11, 2016 - An analysis led by McMaster University researchers has found that women who undergo armpit lymph node surgery for breast cancer are much more likely to develop chronic pain.
read press release 



New Test Predicts Breast Cancer Spread Faster And More Accurately Than NHS Test

(Institute for Cancer Research [UK]) July 10, 2016 - A new test could predict the risk of a woman’s breast cancer spreading within 10 years of diagnosis more accurately than the current NICE-approved test, Oncotype DX, scientists have found.
read article 



AstraZeneca, Sandoz Reach Patent Resolution

(MarketWatch) July 13, 2016 - AstraZeneca PLC has entered an agreement with Sandoz, Inc. and affiliates to resolve a U.S. patent litigation relating to its hormonal therapy drug Faslodex, the British pharmaceutical giant said Wednesday.
read article 



The Unbearably Slow Adoption of Genetic Cancer Tests

(The Atlantic) July 12, 2016 - Discovering genes that increase the risk of tumors is one thing—but actually using that knowledge to help people is another.
read article 



Lilly and Boehringer Ingelheim Announce Clinical Trial Collaboration in Metastatic Breast Cancer

(Lilly) July 13, 2016 - Eli Lilly and Company and Boehringer Ingelheim today announced a new collaboration on a Phase 1b study that will evaluate the safety and tolerability of abemaciclib (LY2835219), Lilly's cyclin-dependent kinase (CDK) 4 and CDK 6 inhibitor, in combination with BI 836845, Boehringer Ingelheim's insulin-like growth factor (IGF)-1/IGF-2 ligand neutralizing antibody, in patients diagnosed with HR+, HER2- mBC.
read corporate press release 



After 3 Patient Deaths, Juno Therapeutics To Resume Modified Trial Of Anti-Cancer Treatment

(KHN Morning Briefing) July 13, 2016 - The FDA is allowing the continuation after the company said that the deaths of the three young leukemia patients — who developed fatal brain swelling — stemmed not from its treatment but from a chemotherapy drug also used. Juno will drop that chemo drug in the modified trial.
read article 



FDA Lets Juno Jump Back Into T-Cell Trial, Minus One Chemo Drug

(Xconomy Seattle) July 12, 2016 - The FDA has allowed Juno Therapeutics to resume a high profile clinical trial of a cutting-edge cancer therapy less than a week after the trial was halted, Juno announced this afternoon. The news has bumped its share price 25 percent in after-hours trading Tuesday.
read article 



Unrealistic Expectations May Hinder Blood Cancer Patients' Care

(Reuters Health) July 12, 2016 - The biggest barrier to high-quality end-of-life care for patients with blood cancers may be unrealistic expectations, a new survey found.
read article 



AstraZeneca Resolves Faslodex Patent Litigation in U.S.

(Reuters) July 13, 2016 - British drugmaker AstraZeneca Plc said on Wednesday it has entered into an agreement with Sandoz, the generic pharmaceuticals division of Novartis AG, to resolve Faslodex patent litigation in the U.S.
read article 



New Hands-Free Device Delivers Monthly Dose of PCSK9 Inhibitor

(Monthly Prescribing Reference) July 11, 2016 - Amgen announced that the Food and Drug Administration (FDA) has approved Repatha (evolocumab) Pushtronex system, an on-body infusor with a prefilled cartridge intended for once-monthly administration.
read article 



Experimental Drug Dramatically Reduces Post-Partum Depression In Small Study

(Forbes) July 12, 2016 - An experimental drug led to remission of post-partum depression in 7 of 10 patients, compared to 1 of 11 patients in a placebo group, boosting hope that the medicine might help women who become so distraught after childbirth that they need to be hospitalized.
read article 



Shire Shares Up After US Approval For New Dry-Eye Disease Treatment

(CNBC/MarketInsider) July 12, 2016 - Shire shares rose more than 3 percent Tuesday after the company won approval from the U.S. Food and Drug Administration for its dry-eye treatment Xiidra.
read article 



Skin Cancer Risk For Freckly Red-Heads Equivalent To 21 Years In Sun

(Reuters) July 12, 2016 - Having genes that give you red hair, pale skin and freckles increases your risk of developing skin cancer as much as an extra 21 years' exposure to the sun, researchers said on Tuesday.
read article 



Virginia Cancer Specialists Receives Clinical Trials Research Award from Conquer Cancer Foundation

(The US Oncology Network) July 12, 2016 - Practice recognized for providing high-quality clinical trials in a community setting.
read press release